Metabolic Disturbance
61
9
11
40
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
1 terminated out of 61 trials
97.6%
+11.1% vs benchmark
7%
4 trials in Phase 3/4
3%
1 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (61)
Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome
Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )
NiPPeR Randomised Trial - Child Follow Up Study
Biomarkers Predicting Acute Myocardial Infraction in Patients Without Standard Modifiable Risk Factors
Remote Time-restricted EAting DeliverY
Multiple Risk Factor Intervention Trial in Breast Cancer Survivors
Multiple Risk Factor Intervention Trial (Ms. FIT)
Metabolic Adaptations to High-fat Diet
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
Diet-Induced Changes in GEnetic Material
The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
Effects of Railway Vibration on Sleep and Disease
Betaine, Exercise Performance, and Gut Permeability
Hemp Fiber Ingestion and Gut Permeability After Exercise
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Smoothies and Blood Sugars
Metabolic Substrate of Patients With Myocardial Infarction With and Without Modifiable Cardiovascular Risk Factors
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs